Seitaro Terakura

Associate professor

Nagoya University Hospital

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Seitaro Terakura is an Associate Professor at Nagoya University Hospital, Japan. His research focuses on allogeneic hematopoietic stem cell transplantation, chimeric antigen receptor T cell therapies, and the immunological responses in transplant recipients. Recent articles include studies on the optimization of Antithymocyte Globulin exposure, dose effects in stem cell transplantation, and the immune response after COVID-19 vaccinations in transplant patients.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (11)

Yosuke Nakaya

Osaka University Graduate School of Medicine

JAPAN

View details

Ryo Hanajiri

Nagoya University Hospital

JAPAN

View details

Shingo Suzuki

Assistant Professor

Tokai University School of Medicine

JAPAN

View details

Eisei Kondo

Professor

Kawasaki Medical School

JAPAN

View details

Peter Steinberger

Medical University of Vienna

AUSTRIA

View details

Keisuke Kataoka

Keio University

JAPAN

View details

Akinao Okamoto

Fujita Health University

JAPAN

View details

Shoichi Iriguchi

Lecturer

Kyoto University

JAPAN

View details

Masahide Osaki

Osaka University Hospital

JAPAN

View details

Akihito Shinohara

Tokyo Women's Medical University

JAPAN

View details

Yutaka Hatanaka

Hokkaido University Hospital

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Seitaro Terakura

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Adjustment of low-dose ATG exposure improves outcomes in allogeneic hematopoietic stem cell transplantation: a prospective multicenter study

Dose Effect of Antithymocyte Globulin or Post-transplant Cyclophosphamide in Haploidentical Peripheral Blood Stem Cell Transplantation: A Comparative Study

Development and optimization of Eva1 (MPZL2) targeting chimeric antigen receptor T cells

Initiating-clone analysis in patients with acute myeloid leukemia secondary to essential thrombocythemia

Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models

Scoring system for optimal cord blood unit selection for single cord blood transplantation

Cullin-5 deficiency promotes chimeric antigen receptor T cell effector functions potentially via the modulation of JAK/STAT signaling pathway

Antibody response after third dose of COVID-19 mRNA vaccination in allogeneic hematopoietic stem cell transplant recipients is comparable to that in healthy counterparts

Impact of donor types on reduced-intensity conditioning allogeneic stem cell transplant for mature lymphoid malignancies

Downregulation of HLA class II is associated with relapse after allogeneic stem cell transplantation and alters recognition by antigen-specific T cells

Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells

Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: real-world evidence

Impact of HLA disparity on the risk of overall mortality in patients with grade II–IV acute GVHD on behalf of the HLA Working Group of Japan Society for Hematopoietic Cell Transplantation

Composite CD79A/CD40 co-stimulatory endodomain enhances CD19CAR-T cell proliferation and survival

Collaborators (11)

Yosuke Nakaya

Ryo Hanajiri

Shingo Suzuki

Eisei Kondo

Peter Steinberger

Keisuke Kataoka

Akinao Okamoto

Shoichi Iriguchi

Masahide Osaki

Akihito Shinohara

Yutaka Hatanaka

Make your next move.